Acquisition by Frost Phillip Md Et Al of 2941177 shares of Cocrystal Pharma at 0.51 subject to Rule 16b-3
| COCP Stock | USD 1.43 0.01 0.70% |
Slightly above 54% of Cocrystal Pharma's investor base is interested to short. The analysis of overall sentiment of trading Cocrystal Pharma stock suggests that many investors are impartial at this time. Cocrystal Pharma's investing sentiment overview a quick insight into current market opportunities from investing in Cocrystal Pharma. Many technical investors use Cocrystal Pharma stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Cocrystal | Build AI portfolio with Cocrystal Stock |
Filed transaction by Cocrystal Pharma Executive. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Cocrystal Pharma's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cocrystal Pharma's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Cocrystal Pharma Fundamental Analysis
We analyze Cocrystal Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cocrystal Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cocrystal Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Cocrystal Pharma is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Cocrystal Pharma Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cocrystal Pharma stock to make a market-neutral strategy. Peer analysis of Cocrystal Pharma could also be used in its relative valuation, which is a method of valuing Cocrystal Pharma by comparing valuation metrics with similar companies.
Peers
Cocrystal Pharma Related Equities
| RNXT | RenovoRx | 3.85 | ||||
| AKTX | Akari Therapeutics | 3.17 | ||||
| IKNA | Ikena Oncology | 2.61 | ||||
| MBRX | Moleculin Biotech | 2.25 | ||||
| ALLR | Allarity Therapeutics | 2.11 | ||||
| TPST | Tempest Therapeutics | 2.70 | ||||
| QNRX | Quoin Pharmaceuticals | 3.20 | ||||
| VRAX | Virax Biolabs | 7.62 | ||||
| CYCC | Cyclacel Pharmaceuticals | 8.57 | ||||
| BDRX | Biodexa Pharmaceticals | 8.70 | ||||
| PULM | Pulmatrix | 9.79 | ||||
| REVB | Revelation Biosciences | 14.98 |
Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.